Nov 11, 2021
Flora Growth Corp. (NASDAQ: FLGC) recently announced the next stage of its development with the creation of Flora Pharma and the execution of an agreement to begin scientific clinical trials globally. Flora Pharma’s formation follows the acknowledgment and commitment by the management team and board of directors to move ahead with applied research initiatives in medical cannabis in order to become a leader in the discovery, development, manufacturing and commercialization of novel, phytocannabinoid-based prescription medicines and nutraceutical products to address a broad range of diseases. The company also signed an agreement to begin scientific clinical trials on the use of cannabinoids to treat fibromyalgia and chronic pain, with the primary research sites for the global effort located in the U.S. and U.K. “Our team is incredibly excited to announce our entry into cannabinoid science,” president and CEO Luis Merchan was quoted in a recent article. “Commercial harvests are well underway, and it is now that we’re able to turn our attention to what we believe is the long-term future of our industry and to hedge ourselves further against the commoditization of raw cannabis materials.”
To view the full article, visit https://cnw.fm/xbrtt
About Flora Growth Corp.
Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]
CannabisNewsWire is part of the InvestorBrandNetwork.
Attackers are exploiting a critical flaw in F5 BIG-IP Access Policy Manager (APM) that lets them run code on a BIG-IP system without logging in, F5 says. The flaw, CVE-2026-94127, affects only systems in which APM serves as an OAuth authorization server, issuing access tokens to applications. F5 disclosed it in an advisory on September 22 and has released engineering hotfixes.
Read moreA Chinese threat actor codenamed UTA0565 has been observed exploiting the recently disclosed Google Chrome-Microsoft Windows exploit chain as zero-days through fake websites. The attacks, detected on September 3 and 4, 2026, involved the chaining of two vulnerabilities in Chrome (CVE-2026-85046, CVE-2026-87491) and one impacting Windows Advanced Local Procedure Call (CVE-2026-85880) to break
Read moreArchaeologists believe they may have uncovered a secret hiding behind the walls of Tutankhamun's tomb.
Read moreVivo V80 launches in India on October 6 with a ZEISS quad-camera system, 50MP main and telephoto sensors, a 6.59-inch 144Hz 1.5K OLED display, a 7,200mAh battery with 90W fast charging, and OriginOS 7 with 30+ AI camera features. Price to be revealed at launch.
Read moreA new security vulnerability in Next.js could allow attackers to run code on a server via ImageResponse, the feature that generates Open Graph and other social preview images, Vercel said. The risk applies when an app puts values an attacker controls, such as text read from the request URL, into the image. Vercel, which develops Next.js, fixed the flaw on September 22 in version
Read moreDespite being the generation that grew up with Tinder, Hinge and Bumble at their fingertips, a study has revealed Gen Z is in a sex recession.
Read moreThe cyber extortion group known as ShinyHunters on Tuesday claimed it had breached the U.S. Federal Bureau of Investigation and stolen data belonging to current and former employees at the agency. "We have compromised the FBI. We hold very sensitive data on almost ALL FBI Agents and individuals who filed an application with the FBI for a job," the group said in a statement posted on their dark
Read moreThe zoo near Canterbury says glutinous snails started laying eggs on their way to Kent.
Read moreShenzhen Camsense Technologies, a maker of spatial sensors for robotic vacuum cleaners, launched a Hong Kong initial public offering (IPO) that aims to raise about HK$680 million (US$86.7 million), despite headwinds from Washington’s recent import ban on foreign-made vacuum robots. “The export and procurement for our existing client products remain normal, with potential disruption limited to new product development schedules,” Camsense co-founder Zhou Kun said about the ban’s impact. “We have...
Read moreMore than 40,000 of the cases – which range from mild coughs to pneumonia – involve toddlers.
Read moreAs World Tourism Day approaches this weekend (Sunday, September 27, 2026), Ireckonu, the leading Hospitality Customer Data Platform (CDP) has called on the industry to unify data for the benefit of both guests and hotels. A recent study by Ireckonu found that hotels are missing out on the opportunity to re-engage up to 20% of guests due to the fragmented nature of accurately capturing their data.
Read moreWorries about an AI internet takeover gain new urgency among doomsday scenarios
Read moreYOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
